Paxlovid didn’t help older adults with long COVID, study shows … What geriatricians should know about monoclonal anti-amyloid antibodies for Alzheimer’s … High salt linked to type 2 diabetes...
CDC: Seniors had lower COVID-19 immunity than rest of population in 2022
By
Alicia Lasek
Jun 05, 2023
The findings highlight the importance for adults aged 65 years and older to stay up to date with COVID-19 vaccination and have easy access to antiviral medications, researchers say.
More than half of Americans now have antibodies against COVID-19, CDC reports
By
Alicia Lasek (f3)
Apr 27, 2022
Nearly 58% of Americans had antibodies to SARS-CoV-2 by February 2022, meaning that a majority of the country’s population has been exposed to the virus, new CDC data reveals.
State to test nursing home residents for antibodies, weigh need for 4th vax
By
Alicia Lasek
Jan 24, 2022
The state of Maryland will test nursing home residents for COVID-19 antibodies in a proactive effort to determine whether or not they should be offered a fourth vaccine dose, Gov. Larry Hogan (R) announced...
Clinical briefs for Thursday, Jan. 6
By
Alicia Lasek
Jan 06, 2022
Fourth COVID-19 vaccine dose boosts antibodies fivefold in Israeli study … ICUs may be spared omicron surge, investigation finds … New anemia drug for kidney dialysis patients may be approved in 2022...
Moderna’s booster neutralizes omicron; protection will last through winter, drugmaker says
By
Alicia Lasek
Dec 21, 2021
At 50 micrograms, a booster of Moderna’s vaccine increases antibody levels by 37-fold against the SARS-CoV-2 omicron variant, the company reported Monday.
Two years into pandemic, we’re better prepared to fight off virus variants
By
Alicia Lasek
Dec 02, 2021
Despite the threat of the quickly spreading and highly mutated omicron coronavirus variant — which has just landed in the U.S. — we are safer than we were before the pandemic, some experts say.
WHO: Antibody treatment most beneficial for seniors, the unvaccinated, and immunocompromised
By
Alicia Lasek
Sep 27, 2021
The World Health Organization’s new guidance for using the REGEN-COV monoclonal antibody cocktail to treat COVID-19 covers a narrower group of patients than those included in the FDA’s updated...
Llama antibodies have ‘significant potential’ for treating COVID, UK health officials say
By
Alicia Lasek
Sep 23, 2021
Llama antibodies have shown resounding success in early efficacy trials in animals. If developed into a drug for humans, they could be administered using a nebulizer or nasal spray, investigators say.
Newly identified ‘auto-antibody’ mechanism may play key role in seniors’ COVID deaths
By
Alicia Lasek
Aug 23, 2021
The finding may explain why some people — and notably older adults — suffer more severe COVID-19 illness than others. The discovery has implications for treatment timing and vaccination, investigators...